Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Michigan Medicaid Gives Preferred Status To SSRIs, Atypical Antipsychotics

Executive Summary

Michigan Medicaid's Rx prior authorization/ supplemental rebate program awards preferred status for drugs in the selective serotonin reuptake inhibitor and atypical antipsychotic classes
Advertisement

Related Content

Medicare Rx Benefit Would Replace Maryland Senior Drug Program
Medicare Rx Benefit Would Replace Maryland Senior Drug Program
New York Medicaid Preferred Drug List Would Save $730 Mil., Report Says
New York Medicaid Preferred Drug List Would Save $730 Mil., Report Says
Mass. Medicaid Advises Against Zyprexa First Line, But No Prior Authorization
Supreme Court Allows Maine Rx; PhRMA Says States Will Delay Similar Plans
Medicaid Supplemental Rebates Upheld By D.C. Federal Court
Medicaid Supplemental Rebates Upheld By D.C. Federal Court
Maine To Resubmit Medicaid Waiver To HHS After Court Strikes Plan Down
Advertisement
UsernamePublicRestriction

Register

PS042097

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel